Drug intelligence / Profile preview

ARTS mimetic peptides

Development stage
Preclinical
Modality
Peptides
Administration
Intratumoral, Intravenous
01

Overview

ARTS mimetic peptides are synthetic peptides designed to mimic the pro-apoptotic function of the mitochondrial tumor suppressor protein ARTS (also known as Sept4_i2). These peptides are derived from the unique C-terminal domain of ARTS, specifically the ARTS-IAP-binding motif (AIBM). They act by directly binding to the BIR3 domain of X-linked inhibitor of apoptosis protein (XIAP), promoting its auto-ubiquitylation and subsequent degradation via the ubiquitin-proteasome system (UPS). This degradation relieves the inhibition of caspases (such as caspase-3 and caspase-9), thereby triggering apoptotic cell death in cancer cells. Research has demonstrated their potential in treating various cancers, including glioblastoma, where they have been evaluated in combination with autophagy inhibitors to overcome apoptosis resistance.

Other names
AIBM peptidesAIBM-based peptidesARTS-derived peptidesARTS-IBM peptidesARTS-mimetic peptides
02

Targets

BCL-2 (BCL-2 family)XIAP

Beyond the preview

Go deeper on ARTS mimetic peptides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARTS mimetic peptides.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call